Enhanced phosphorylation of phospholamban and downregulation of sarco/endoplasmic reticulum Ca2+ ATpase type 2 (SERCA 2) in cardiac sarcoplasmic reticulum from rabbits with heart failure

Cardiovascular Research

Volumn 41, Issue 1, 1999, Pages 135-146

  Currie, Susan ^a   Smith, Godfrey L ^a  

^a UNIVERSITY OF GLASGOW   (United Kingdom)

Author keywords

Ca2+ uptake; Heart failure; Phospholamban; Phosphorylation; Rabbit; Sarcoplasmic reticulum; SERCA 2

Indexed keywords

1 [N,O BIS(5 ISOQUINOLINESULFONYL) N METHYLTYROSYL] 4 PHENYLPIPERAZINE; ADENOSINE TRIPHOSPHATASE (CALCIUM); CALCIUM ION; FURA 2; PHOSPHOLAMBAN; PROTEIN KINASE C INHIBITOR; PROTEIN KINASE INHIBITOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CALCIUM TRANSPORT; CONTROLLED STUDY; CORONARY ARTERY LIGATION; DENSITOMETRY; HEART FAILURE; IMMUNOBLOTTING; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; RABBIT; SARCOPLASMIC RETICULUM;

ANIMALS; CALCIUM; CALCIUM-BINDING PROTEINS; CALCIUM-TRANSPORTING ATPASES; HEART FAILURE, CONGESTIVE; IMMUNOBLOTTING; MALE; MYOCARDIUM; PHOSPHORYLATION; RABBITS; SARCOPLASMIC RETICULUM;

EID: 0032903877     PISSN: 00086363     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0008-6363(98)00241-7     Document Type: Article

References (36)

1. Afzal N, Dhalla NS. Differential changes in left ventricular and right ventricular SR calcium transport in congestive heart failure. Am J Physiol 1992;262:H868-H874.
2. Afzal N, Dhalla NS. Sarcoplasmic reticular Ca pump ATPase activity in congestive heart failure due to myocardial infarction. Can J Cardiol 1996;12:1065-1073.
3. Arai M, Matsui H, Periasamy M. Sarcoplasmic reticulum gene expression in cardiac hypertrophy and heart failure. Circ Res 1994;74:555-563.
4. Baltas LG, Karczewski P, Krause E. The cardiac sacroplasmic reticulum phospholamban kinase is a distinct delta-CaM kinase isozyme. FEBS Lett 1995;373:71-75.
5. Beuckelmann DJ, Nabauer M, Erdmann E. Intracellular calcium handling in isolated ventricular myocytes from patients with terminal heart failure. Circulation 1992;85:1046-1055.
6. Boateng S, Seymour AL, Dunn M, Yacoub MH, Boheler KR. Inhibition of endogenous cardiac phosphatase activity and measurement of sarcoplasmic reticulum calcium uptake: a possible role of phospholamban phosphorylation in hypertrophied myocardium. Biochem Biophys Res Commun 1997;239:701-705.
7. 2+ transport properties. J Biol Chem 1983;258:6602-6609.
8. Davies CH, Harding SE, Poole-Wilson PA. Cellular mechanisms of contractile dysfunction in human heart failure. Eur Heart J 1996;17:189-198.
9. Drago GA, Colyer J. Discrimination between two sites of phosporylation on adjacent amino acids by phosphorylation site-specific antibodies to phospholamban. J Biol Chem 1994;269:25073-25077.
10. Grynkiewicz G, Poenie M, Tsien RY. A new generation of Ca indicators with greatly improved flourescence properties. J Biol Chem 1985;260:3440-3450.
11. Gupta RC, Tanimura M, Lesch M, Sabbah HN. Protein phosphatase activity is increased and state of phosphorylation of phospholamban is decreased in myocardium of dogs with chronic heart failure. Circulation 1997;96:2021.
12. Gwathmey JK, Copelas L, MacKinnon R, et al. Abnormal intracellular calcium handling in myocardium from patients with end-stage heart failure. Circ Res 1987;61:70-76.
13. Gwathmey JK, Morgan JP. Altered calcium handling in experimental pressure-overload hypertrophy in the ferret. Circ Res 1985;57:836-843.
14. Harrer JM, Kiss E, Kranias EG. Application of immunoblot technique for quantification of protein levels in cardiac homogenates. Biotechniques 1995;18:995-998.
15. Hasenfuss G, Meyer M, Schillinger W, et al. Calcium handling proteins in the failing human heart. Basic Res Cardiol 1997;92:87-93.
16. 2+-ATPase in failing and nonfailing human myocardium. Circ Res 1994;75:434-442.
17. 2+ -pump stimulation. Biochem J 1996;316:201-207.
18. 2+ transport and mechanics in compensated pressure overload and mechanics in compensated pressure overloaded hypertrophy and congestive heart failure. Circ Res 1995;77:759-764.
19. Koss KL, Kranias EG. Phospholamban: a prominent regulator of myocardial contractility. 79;1996:1059-1063.
20. 2+ selective channels in lipid bilayers. J Biol Chem 1988;263:18364-18368.
21. Laemmli UK. Cleavage of structural proteins during the assembly of the head bacteriophage T4. Nature 1970;227:680-685.
22. Li C, Wang JH, Colyer J. Immunological detection of phospholamban phosphorylation states facilitates the description of the mechanism of phosphorylation and dephosphorylation. Biochemistry 1990;29:4535-4540.
23. MacDougall LK, Jones LR, Cohen P. Identification of the major protein phosphatases in mammalian cardiac muscle which dephosphorylates phospholamban. Eur J Biochem 1990;196:725-734.
24. Meyer M, Schillinger W, Pieske B, et al. Alterations of SR proteins in failing human dilated cardiomyopathy. Circulation 1995;92:778-784.
25. 2+ uptake in sarcoplasmic reticulum from normal and failing hearts. J Clin Invest 1990;85:1698-1702.
26. Movsesian MA, Leveille C, Krall J. Identification and characterization of proteins in sarcoplasmic reticulum from normal and failing human left ventricles. J Mol Cell Cardiol 1990;22:1477-1485.
27. Mundina-Weilmann C, Vittone L, Ortale M, Chiappe de Cingolani G, Mattiazzi A. The effect of acidosis on the phosphorylation of phospholamban and troponin-I in rat cardiac muscle. J Biol Chem 1991;271:33561-33567.
28. Neary P, Duncan AM, Cobbe SM, Smith GL. Reduced sarcoplasmic reticulum Ca-ATPase dpendant Ca uptake in isolated ventricular myocytes from failing rabbit hearts. Heart 1998;79:41.
29. Ng GA, Cobbe SM, Smith GL. Non-uniform prolongation of intracellular Ca transients recorded from the epicardial surface of isolated hearts from rabbits with heart failure. Cardiovasc Res 1998;37:489-502.
30. Pye MP, Black M, Cobbe SM. Comparison of in vivo and in vitro hemodynamics function in experimental heart failure - use of echocardiography. Cardiovasc Res 1996;31:873-881.
31. 2+-ATPase during progression of left ventricular hypertrophy. Am J Physiol 1997;272:H2416-H2424.
32. 2+ pump ATPase by phospholamban in cardiac sarcoplasmic reticulum. J Biol Chem 1992;267:1674-1677.
33. Schmidt U, Hajjar RJ, Charlton SC, Gwathmey JK. Reduced phosphorylation level of phospholamban in human heart failure. Circulation 1997;94:1479.
34. Schwinger RHG, Bohm M, Schmidt U, et al. Unchanged protein levels of SERCAII and phospholamban but reduced Ca uptake and Ca -ATPase activity of cardiac SR from dilated cardiomyopathy patients compared with patients with non-failing hearts. Circulation 1995;92:3220-3228.
35. Siri FM, Krueger J, Nordin C, Ming Z, Aronson RS. Depressed intracellular calcium transients and contraction in myocytes from hypertrophied and failing guinea pig hearts. Am J Physiol 1991;261:H514-H530.
36. Zarain-Herzberg A, Afzal N, Elimban V, Dhalla NS. Decreased expression of cardiac sarcoplasmic reticulum Ca(2+)-pump ATPase in congestive heart failure due to myocardial infarction. Mol Cell Biochem 1996;163-164:285-190.